PTPRJ and cancer: While no PTPRJ copy number variants (CNVs) were found in > 2650 cancer-free controls, the screening of an additional cohort of ~1500 CRC patients detected a 564-kb duplication in a 39-year-old CRC patient, also causing PTPRJ promoter methylation [99].